Steger, GG; Greil, R; Jakesz, R; Lang, A; Mlineritsch, B; Melbinger-Zeinitzer, E; Martin, C; Samonigg, H; Kubista, E; Gnant, M.
A randomized phase III study comparing epirubicin, docetaxel, and capecitabine (EDC) to epirubicin and docetaxel (ED) as neoadjuvant treatment for early breast cancer - first results of the Austrian Breast and Colorectal Cancer Study Group-Trial 24 (ABCSG-24)
EJC SUPPL. 2009; 7(3):3-3.
Doi: 10.1016/S1359-6349(09)72030-0
[Oral Communication]
Web of Science
FullText
FullText_MUG